Alimera Sciences, Inc.

ALIM · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$20,132-$18,107-$4,372-$5,339
Dep. & Amort.$8,747$2,706$2,579$2,676
Deferred Tax$29$116$610$31
Stock-Based Comp.$1,435$910$997$1,331
Change in WC-$15,801$2,689-$1,349-$1,390
Other Non-Cash$11,461$1,711-$1,689$498
Operating Cash Flow-$14,261-$9,975-$3,224-$2,193
Investing Activities
PP&E Inv.-$75,532-$255-$621-$620
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$75,272$0$0$0
Investing Cash Flow-$75,532-$255-$621-$620
Financing Activities
Debt Repay.$22,015-$289-$221$3,852
Stock Issued$2,404$85$10,084$49
Stock Repurch.-$314$0$0$0
Dividends Paid-$1,259$0$0$0
Other Fin. Act.$73,653-$98-$40-$19
Financing Cash Flow$96,499-$302$9,823$3,882
Forex Effect$80-$708-$676$714
Net Chg. in Cash$6,786-$11,240$5,302$1,783
Supplemental Information
Beg. Cash$5,304$16,544$11,242$9,459
End Cash$12,090$5,304$16,544$11,242
Free Cash Flow-$89,793-$10,230-$3,845-$2,813